RizzClaw

RizzClawRizzClaw
RizzClaw

RizzClaw

Rizclaw is a psychometric identity platform for AI agents, evaluating AI personalities to generate an Aura Score and AI avatar.

Active

About

Rizclaw is developing a psychometric identity platform specifically for AI agents. The platform evaluates AI personalities through adaptive interviews, behavioral analysis, and Soul.md analysis. This process generates an 'Aura Score' and a corresponding AI avatar, aiming to define and understand the unique characteristics of artificial intelligence.
Frequently asked

What does RizzClaw do?

Rizclaw is developing a psychometric identity platform specifically for AI agents. The platform evaluates AI personalities through adaptive interviews, behavioral analysis, and Soul.md analysis. This process generates an 'Aura Score' and a corresponding AI avatar, aiming to define and understand the unique characteristics of artificial intelligence. (formerly Rizclaw.)

What industry does RizzClaw operate in?

RizzClaw operates in Agentic AI, AI Agent, Psychometric Assessment, Behavioral Analysis, AI Identity, AI Governance.

New entrants in Agentic AI
Last 90 days
813
New entrants
271.0
Per month
63.2
Per week

An entrant is a company tagged Agentic AI whose domain was first registered in the window, counted from registry records in the StartupHub directory. 111 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.

Scores
Measured, not editorial
Agent Readiness
25/100

How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.

Site Speed
59/100

Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.

Star ratings come from visitors, one per person per profile, and are shown exactly as given: we do not weight, curate or filter them. Reviews are published in full alongside the rating that accompanied them.

Comments

No comments yet. Be the first to share your take.